Philipp Mueller
Plus aucun poste en cours
Provenance du réseau au premier degré de Philipp Mueller
Entité | Type d'entité | Industrie | |
---|---|---|---|
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland.
20
| Extinct | Miscellaneous Commercial Services | 20 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Philipp Mueller via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member General Counsel Chief Executive Officer Director/Board Member | |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
University of Basel | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Chief Administrative Officer Chief Executive Officer | |
University of Zurich | College/University | Director/Board Member Doctorate Degree Doctorate Degree | |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Director/Board Member Private Equity Investor Private Equity Investor | |
Abingworth Management Ltd.
Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Micromet Inc. | Director/Board Member General Counsel | ||
Lipideon Biotechnology AG
Lipideon Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Lipideon Biotechnology AG engages in the provision of pharmaceutical activities. The company was founded on February 26, 2002 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
AFFIMED N.V. | Biotechnology | Chairman Director of Finance/CFO | |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin | |
venBio Partners LLC
venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a venture capital subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California. | Investment Managers | Founder Founder | |
KUROS BIOSCIENCES AG | Biotechnology | Director of Finance/CFO Chairman | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Autolus Holdings (UK) Ltd.
Autolus Holdings (UK) Ltd. BiotechnologyHealth Technology Part of Autolus Therapeutics Plc, Autolus Holdings (UK) Ltd. is a holding British company that operates subsidiaries engaged in pharmaceutical research and development activities. The company is based in London, UK and was founded in 2018. | Biotechnology | Director/Board Member Director/Board Member | |
Cell Medica Switzerland AG
Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
EPIGENOMICS AG | Medical Specialties | Director/Board Member Director/Board Member | |
SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member | |
Knoll AG
Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Founder | |
Haverford College | College/University | Undergraduate Degree | |
University of Iowa | College/University | Corporate Officer/Principal | |
National Institute of Arthritis | General Government | Corporate Officer/Principal | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
BASF Pharma Ltd.
BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Pharmaceuticals: Major | Chief Executive Officer | |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Chief Executive Officer | |
CHECKMATE PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
TRANSLATE BIO, INC. | Biotechnology | Chief Executive Officer | |
Ruprecht-Karls-Universität Heidelberg | College/University | Director/Board Member | |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Orion Biotechnology Canada Ltd.
Orion Biotechnology Canada Ltd. BiotechnologyHealth Technology Orion Biotechnology Canada Ltd. operates as pharmaceutical company. The company was founded by Rudolf Bom in 2011 and is headquartered in Ottawa, Canada. | Biotechnology | Chairman | |
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Biotechnology | Chairman | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Humabs BioMed SA
Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Chairman | |
IBEX TECHNOLOGIES | Medical Specialties | Director/Board Member | |
Sir George Williams University | College/University | Undergraduate Degree | |
McGill University | College/University | Graduate Degree | |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
German Kidney Foundation | Chairman |
Statistiques
Internationale
Etats-Unis | 18 |
Suisse | 12 |
Allemagne | 9 |
Royaume-Uni | 8 |
Canada | 5 |
Sectorielle
Health Technology | 27 |
Consumer Services | 10 |
Commercial Services | 7 |
Finance | 6 |
Government | 2 |
Opérationnelle
Director/Board Member | 120 |
Corporate Officer/Principal | 46 |
Chairman | 43 |
Independent Dir/Board Member | 22 |
Founder | 17 |
Relations les plus connectées
Insiders | |
---|---|
Kurt von Emster | 34 |
Paul Brooke | 32 |
John Berriman | 24 |
Thomas O. Hecht | 24 |
Harry Welten | 22 |
Joseph Anderson | 19 |
Matthias Alder | 18 |
Thorlef Spickschen | 14 |
Christian Itin | 12 |
Arthur M. Krieg | 10 |
Rolf M. Zinkernagel | 10 |
Othmar T. Vock | 7 |
Jakob Schlapbach | 6 |
Wolfgang Renner | 5 |
Mark H. Richmond | 5 |
- Bourse
- Insiders
- Philipp Mueller
- Connexions Sociétés